Chancheewa B, Asawanonda P, Noppakun N, Kumtornrut C
Skin Appendage Disord. 2022; 8(6):469-475.
PMID: 36407643
PMC: 9672862.
DOI: 10.1159/000524566.
Ribatti D, Tamma R, Annese T, Ingravallo G, Specchia G
Front Oncol. 2022; 12:964573.
PMID: 36313712
PMC: 9606700.
DOI: 10.3389/fonc.2022.964573.
Muire P, Thompson M, Christy R, Natesan S
Int J Mol Sci. 2022; 23(8).
PMID: 35456892
PMC: 9032453.
DOI: 10.3390/ijms23084074.
Ikeda T, Nakamura K, Sato T, Kida T, Oku H
Int J Mol Sci. 2021; 22(4).
PMID: 33572210
PMC: 7914697.
DOI: 10.3390/ijms22041724.
Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E
Front Cell Dev Biol. 2021; 8:607483.
PMID: 33409282
PMC: 7779530.
DOI: 10.3389/fcell.2020.607483.
Catechin synergistically potentiates mast cell-stabilizing property of caffeine.
Yashima M, Sato Y, Kazama I
Allergy Asthma Clin Immunol. 2021; 17(1):1.
PMID: 33407842
PMC: 7789391.
DOI: 10.1186/s13223-020-00502-5.
-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells.
Abe N, Toyama H, Ejima Y, Saito K, Tamada T, Yamauchi M
Biomed Res Int. 2020; 2020:3214186.
PMID: 32461978
PMC: 7243011.
DOI: 10.1155/2020/3214186.
Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen.
Limberg A, Tibbo M, Salib C, McLaury A, Turner T, Berry C
J Orthop Res. 2020; 38(11):2474-2483.
PMID: 32134136
PMC: 7483403.
DOI: 10.1002/jor.24647.
Delayed Rectifier K-Channel Is a Novel Therapeutic Target for Interstitial Renal Fibrosis in Rats with Unilateral Ureteral Obstruction.
Abe N, Toyama H, Saito K, Ejima Y, Yamauchi M, Mushiake H
Biomed Res Int. 2019; 2019:7567638.
PMID: 31828127
PMC: 6885154.
DOI: 10.1155/2019/7567638.
A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms.
Elieh Ali Komi D, Khomtchouk K, Santa Maria P
Clin Rev Allergy Immunol. 2019; 58(3):298-312.
PMID: 30729428
DOI: 10.1007/s12016-019-08729-w.
PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.
Pincha N, Hajam E, Badarinath K, Batta S, Masudi T, Dey R
J Clin Invest. 2018; 128(5):1807-1819.
PMID: 29584619
PMC: 5919880.
DOI: 10.1172/JCI99088.
Skin Mast Cell Promotion in Random Skin Flaps in Rats using Bone Marrow Mesenchymal Stem Cells and Amniotic Membrane.
Chehelcheraghi F, Abbaszadeh A, Tavafi M
Iran Biomed J. 2018; 22(5):322-30.
PMID: 29506347
PMC: 6058190.
DOI: 10.29252/ibj.22.5.322.
Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts.
Antebi B, Zhang L, Sheyn D, Pelled G, Zhang X, Gazit Z
Bioengineering (Basel). 2016; 3(1).
PMID: 27141513
PMC: 4851447.
DOI: 10.3390/bioengineering3010006.
Role of mast cells in fibrosis of classical Hodgkin lymphoma.
Nakayama S, Yokote T, Hiraoka N, Nishiwaki U, Hanafusa T, Nishimura Y
Int J Immunopathol Pharmacol. 2016; 29(4):603-611.
PMID: 27095287
PMC: 5806829.
DOI: 10.1177/0394632016644447.
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
Del Rio C, Navarrete C, Collado J, Bellido M, Gomez-Canas M, Pazos M
Sci Rep. 2016; 6:21703.
PMID: 26887982
PMC: 4757881.
DOI: 10.1038/srep21703.
Cytokines in the immunopathology of systemic sclerosis.
Raja J, Denton C
Semin Immunopathol. 2015; 37(5):543-57.
PMID: 26152640
DOI: 10.1007/s00281-015-0511-7.
Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.
Monument M, Hart D, Salo P, Befus A, Hildebrand K
Adv Wound Care (New Rochelle). 2015; 4(3):137-151.
PMID: 25785237
PMC: 4352697.
DOI: 10.1089/wound.2013.0509.
Diagnostic and therapeutic strategies for eosinophilic esophagitis.
Zaidi A, Mussarat A, Mishra A
Clin Pract (Lond). 2014; 11(3):351-367.
PMID: 25400904
PMC: 4230789.
DOI: 10.2217/cpr.14.31.
The Importance of Mast Cells in Dermal Scarring.
Wilgus T, Wulff B
Adv Wound Care (New Rochelle). 2014; 3(4):356-365.
PMID: 24757590
PMC: 3985512.
DOI: 10.1089/wound.2013.0457.
A Paradigm of Fibroblast Activation and Dermal Wound Contraction to Guide the Development of Therapies for Chronic Wounds and Pathologic Scars.
Levinson H
Adv Wound Care (New Rochelle). 2014; 2(4):149-159.
PMID: 24527338
PMC: 3840547.
DOI: 10.1089/wound.2012.0389.